872 related articles for article (PubMed ID: 26404926)
1. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
Insel RA; Dunne JL; Atkinson MA; Chiang JL; Dabelea D; Gottlieb PA; Greenbaum CJ; Herold KC; Krischer JP; Lernmark Å; Ratner RE; Rewers MJ; Schatz DA; Skyler JS; Sosenko JM; Ziegler AG
Diabetes Care; 2015 Oct; 38(10):1964-74. PubMed ID: 26404926
[TBL] [Abstract][Full Text] [Related]
2. Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity.
Siljander HT; Hermann R; Hekkala A; Lähde J; Tanner L; Keskinen P; Ilonen J; Simell O; Veijola R; Knip M
Eur J Endocrinol; 2013 Oct; 169(4):479-85. PubMed ID: 23904276
[TBL] [Abstract][Full Text] [Related]
3. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk.
Mustonen N; Siljander H; Peet A; Tillmann V; Härkönen T; Ilonen J; Hyöty H; Knip M;
Pediatr Diabetes; 2018 Mar; 19(2):293-299. PubMed ID: 28597957
[TBL] [Abstract][Full Text] [Related]
4. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
[TBL] [Abstract][Full Text] [Related]
5. Reduced β-cell function in early preclinical type 1 diabetes.
Koskinen MK; Helminen O; Matomäki J; Aspholm S; Mykkänen J; Mäkinen M; Simell V; Vähä-Mäkilä M; Simell T; Ilonen J; Knip M; Veijola R; Toppari J; Simell O
Eur J Endocrinol; 2016 Mar; 174(3):251-9. PubMed ID: 26620391
[TBL] [Abstract][Full Text] [Related]
6. Staging of preclinical type 1 diabetes in siblings of affected children. Childhood Diabetes in Finland Study Group.
Mrena S; Savola K; Kulmala P; Akerblom HK; Knip M
Pediatrics; 1999 Oct; 104(4 Pt 1):925-30. PubMed ID: 10506236
[TBL] [Abstract][Full Text] [Related]
7. [Predisposition, early stages and phenotypes of type 1 diabetes].
Achenbach P; Winkler C; Haupt F; Beyerlein A; Ziegler AG
Dtsch Med Wochenschr; 2014 May; 139(21):1100-4. PubMed ID: 24823976
[No Abstract] [Full Text] [Related]
8. ISPAD Clinical Practice Consensus Guidelines 2014. Phases of type 1 diabetes in children and adolescents.
Couper JJ; Haller MJ; Ziegler AG; Knip M; Ludvigsson J; Craig ME;
Pediatr Diabetes; 2014 Sep; 15 Suppl 20():18-25. PubMed ID: 25325095
[No Abstract] [Full Text] [Related]
9. Screening, staging, and naming of presymptomatic type 1 diabetes.
Becker D; Insel R
Pediatr Diabetes; 2018 Feb; 19(1):7-10. PubMed ID: 29193499
[No Abstract] [Full Text] [Related]
10. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M
Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
12. Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany.
Ziegler AG; Kick K; Bonifacio E; Haupt F; Hippich M; Dunstheimer D; Lang M; Laub O; Warncke K; Lange K; Assfalg R; Jolink M; Winkler C; Achenbach P;
JAMA; 2020 Jan; 323(4):339-351. PubMed ID: 31990315
[TBL] [Abstract][Full Text] [Related]
13. Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes.
Vecchio F; Lo Buono N; Stabilini A; Nigi L; Dufort MJ; Geyer S; Rancoita PM; Cugnata F; Mandelli A; Valle A; Leete P; Mancarella F; Linsley PS; Krogvold L; Herold KC; Elding Larsson H; Richardson SJ; Morgan NG; Dahl-Jørgensen K; Sebastiani G; Dotta F; Bosi E; ; ; Battaglia M
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232284
[TBL] [Abstract][Full Text] [Related]
14. Disease-Modifying Therapies in Type 1 Diabetes: A Look into the Future of Diabetes Practice.
Greenbaum C; VanBuecken D; Lord S
Drugs; 2019 Jan; 79(1):43-61. PubMed ID: 30612319
[TBL] [Abstract][Full Text] [Related]
15. The multiple origins of Type 1 diabetes.
Pugliese A
Diabet Med; 2013 Feb; 30(2):135-46. PubMed ID: 23181718
[TBL] [Abstract][Full Text] [Related]
16. Controversies in medicine: redefining the diagnosis of type 1 diabetes.
Couper JJ; Harrison LC
Med J Aust; 2019 Aug; 211(4):157-159.e1. PubMed ID: 31318055
[No Abstract] [Full Text] [Related]
17. Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes.
Pacaud D; Nucci AM; Cuthbertson D; Becker DJ; Virtanen SM; Ludvigsson J; Ilonen J; Knip M;
Diabetologia; 2021 Jan; 64(1):119-128. PubMed ID: 33026463
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk factors for type 1 diabetes.
Pociot F; Lernmark Å
Lancet; 2016 Jun; 387(10035):2331-2339. PubMed ID: 27302272
[TBL] [Abstract][Full Text] [Related]
19. Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: implications for early screening.
Chmiel R; Giannopoulou EZ; Winkler C; Achenbach P; Ziegler AG; Bonifacio E
Diabetologia; 2015 Feb; 58(2):411-3. PubMed ID: 25409656
[No Abstract] [Full Text] [Related]
20. The fallacy of reduction.
Rewers M
Pediatr Diabetes; 2012 Jun; 13(4):340-3. PubMed ID: 22059463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
